A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.
We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.
We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.
Definition medical devices.
Latest release accelerates hit-to-candidate progression by keeping teams aligned, eliminating inefficiencies and enabling better prioritisation decisions
The partnership will allow HeartBeam to provide a 24/7 cardiology reader service designed to support patients experiencing cardiac symptoms outside of the traditional healthcare system — providing expert, timely assessment during critical moments
A device-based therapy for patients with uncontrolled hypertension whose blood pressure cannot be properly managed with lifestyle changes and medication
Compared to other surgical techniques for this type of injury, this procedure yields a strong and effective repair, and ideally, a faster recovery
Vertex Pulmonary Embolectomy System demonstrated significant right heart recovery, low adverse event rates, and reproducible performance across high-severity PE patients
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes
The technology is customized to each patient’s breast and tumor via 3D printing
“By integrating Oxford Nanopore’s direct RNA sequencing into Lonza’s QC environment, we are enabling a more comprehensive and scalable approach to mRNA quality control,” said Francis Van Parys, CEO, Oxford Nanopore Technologies
Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases
This evolution formalizes Mopec Group's commitment to developing integrated, technology-driven solutions that enhance how pathology laboratories document, manage, and move through the diagnostic workflow
With this funding, TactoTek will accelerate the adoption of IMSE globally by expanding customer-facing operations and streamlining IMSE solution design by augmenting our software-based delivery system with AI elements and plug-ins for CAD and simulation packages
“GPx’s innovative approach to heart monitoring and chronic disease management is a perfect fit for the NEC Group’s vision of leveraging advanced technology to improve quality of life,” said Shintaro Matsumoto, President and CEO of NEC X. “By joining forces with GPx, we aim to enhance their predictive algorithms and capabilities. Together, we can transform the healthcare industry.”
Derek Herrera, founder and CEO of Bright Uro. “With this funding, we are well resourced for the launch of Glean in 2025, while also continuing to resource our pipeline of innovation. We have never been more confident in the expected impact Glean will have for clinicians and millions of patients suffering from urinary issues.”
The funding will accelerate the commercialization of the Nuclera eProtein Discovery platform, to optimize protein expression and purification workflows within research labs globally
When it comes to reproductive care, more options, more accessibility, more affordability and a better focus on women’s choices should be everyone’s goal for the medical community by 2030.
Along with the rising sophistication of inpatient medical devices, data acuity in remote patient monitoring devices is also on the rise. Virtual telemetry, for example, enables the continuous collection of health data like heart rate and blood pressure from nearly anywhere a patient may be located.
Both HFE and UE are based on the international usability standards IEC 62366-1 and IEC 62366-2 with consideration of risk management (ISO 14971). By planning and integrating usability testing for human interaction with medical device technology throughout the device lifecycle and risk management processes, HFE/UE ensures that medical devices meet the complex needs of healthcare professionals and patients, and that user-related and use-related risks are eliminated or mitigated.
Our expert writes: Historically, medical device companies have provided value by producing equipment for diagnosing and treating patients worldwide. However, contemporary challenges such as heightened pricing pressures, regulatory compliance, supply chain volatility and operational inefficiencies have significantly changed the landscape for these companies.
IDE approval in both countries follows strong feasibility clinical results in France.
With this clearance, Maestro Systems can now have active Wi-Fi and 5G connectivity, enabling seamless data exchange with Maestro Insights—Moon’s cloud-based platform that gives surgical teams and administrators access to actionable insights from procedural data.
“Deborah Andrews has blended seamlessly with the leadership team, and we quickly realized that her deep knowledge of STAAR and her skills, abilities, and approach made her the perfect choice to be STAAR’s next CFO,” said the Company’s CEO and Board member, Stephen Farrell.
In this role, Greg Kraus will lead project and operational excellence initiatives across Allient sites contributing to defense market solutions, while also serving as General Manager of Allient’s Watertown, NY facility.
Chris Locke brings over two decades of global experience in medical device R&D, technology strategy, and organisational transformation.
Dr. Beddingfield is a 22-year veteran of the biopharma industry
“For patients in need of cardiovascular or cardiothoracic imaging, the SpotLight Duo is the first cardiothoracic CT incorporating all of Arineta’s patient centric technologies. With one heartbeat, we can provide both high-temporal as well as iso-temporal resolution images that can be used for comprehensive cardiac and thoracic CT assessment,” said Doug Ryan, CEO of Arineta
AI-Guded Ultrasound System Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, and ThinkSono, a pioneering medical technology company specializing in ultrasound artificial
Building on its ZEISS Medical Ecosystem, several of the new innovations enable seamless data integration and management across the cataract and refractive workflows, creating a new standard for efficient, personalized ophthalmic care.
MinXray MinXray, a leading manufacturer of imaging systems for medical and veterinary use, recently sent its Impact Wireless X-ray system with a group of researchers
If you’ve ever watched a medical device rep dart between hospitals, you know the job isn’t just about pitching a product. They’re up before sunrise,
In the competitive field of medical technology, the business of launching a new device is multifaceted
If you’re delving into laboratory sciences, understanding the core principles and applications of ELISAs can significantly enhance your knowledge
